ARTICLE | Company News
KalVista ophthalmic news
September 30, 2013 7:00 AM UTC
KalVista joined the Drug Discovery and Development of Novel Eye Therapeutics (3D-NET) consortium. The four-year project is developing new drugs to treat ocular disease associated with inflammation, ne...